CTOs on the Move

Ocular Therapeutix

www.ocutx.com

 
Founded in 2006, Ocular Therapeutix is a fast-growing, aspiring leader in the biopharmaceutical industry. The company has a clear vision – to improve current therapeutic options in ophthalmology by encapsulating previously approved therapeutic agents in our novel hydrogel to provide a sustained delivery of drugs to the eye. We are reframing the industry with new modalities for ophthalmic therapies. As a small company, our employees are provided the unique opportunity to help build the foundation of the business as it grows. We strongly believe that our success is contingent upon the achievements of our employees. We strive to create a ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.ocutx.com
  • 34 Crosby Drive Ste 105
    Bedford, MA USA 01730
  • Phone: 781.357.4000

Executives

Name Title Contact Details
Steve Fedan
 Director of Information Technology Profile

Funding

Ocular Therapeutix raised $35.1M on 01/30/2018

Similar Companies

Can-Am Care

Can-Am Care is a Alpharetta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Procyrion

Procyrion is developing the first catheter-deployed circulatory assist device intended for long-term use. The Procyrion device will be the first minimally invasive tool for cardiologists to treat over 1M NYHA Class III and early class IV heart failure (HF) patients in the US who have few therapeutic options. In partnership with Texas Heart Institute, Procyrion is currently conducting preclinical testing of the Procyrion device.

Corindus

Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The company`s CorPath® System is the first FDA-cleared medical device to bring robotic-assisted precision to radial, coronary and peripheral procedures. During the procedure, the interventional cardiologist sits at a radiation-shielded workstation to advance stents and guidewires with millimeter-by-millimeter precision. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. With the CorPath System, Corindus Vascular Robotics brings robotic precision to radial and complex interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement with manual procedures. Corindus stands behind its product with its unique $1,000 hospital credit "One Stent Program."

Smart MD

Smart MD is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Chemogen

Chemogen is a South Portland, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.